2025年全球組織診斷市場報告

近年來，組織診斷市場快速擴張，規模從2024年的57.7億美元成長至2025年的63.8億美元，複合年成長率達10.5%。預測期內的成長主要受人口老化、癌症疫情、技術進步、疾病認知度提升、病理工作流程效率提升等因素所驅動。

預計未來幾年組織診斷市場將快速成長，到2029年將達到105.8億美元，複合年成長率為13.5%。預測期內的成長歸因於個人化醫療的發展、液態切片的興起、人工智慧和機器學習的普及、遠端病理學的擴展以及微創技術。預測期內的主要趨勢包括數位病理學、人工智慧 (AI)、遠端病理學服務、多重染色和成像以及基因組數據整合。

組織學是一種醫療程序，其中使用儀器取出組織，染色，然後送到實驗室或病理學部門進行記錄（組織學），用於患者護理，提供測量和描述，包括存在或不存在異常，以及根據適用法律對健康或疾病狀態的解釋（或診斷）。

組織診斷的主要產品類型包括耗材、抗體、試劑套件、試劑、探針、儀器、玻片染色系統、掃描器和組織處理系統。抗體用於檢測感染疾病、識別過敏症以及在組織診斷中測量血液中的荷爾蒙和其他生物標記。組織診斷中使用的技術包括免疫組織化學 (IHC)、原位雜合反應(ISH)、數位病理學和工作流程管理以及用於檢測乳癌、胃癌、淋巴瘤、前列腺癌和非小細胞肺癌 (NSCLC) 等疾病的特殊染色。組織診斷主要由醫院、實驗室、製藥公司和合約研究組織使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供組織診斷市場統計數據，例如全球組織診斷行業市場規模、區域佔有率、競爭對手的市場佔有率、詳細的組織診斷細分市場、市場趨勢和商機，以及您在組織診斷行業取得成功所需的數據。本組織診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們對該市場未來五年13.5%的成長率預測與先前保持不變。下降主要源自於美國與其他國家之間關稅的影響。這將對美國造成直接影響，導致來自丹麥和瑞典等主要地區的免疫組織化學抗體和自動染色試劑供應鏈中斷，這可能導致癌症檢測延遲和病理檢測成本增加。此外，由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

預計癌症發生率的上升將在未來幾年推動組織診斷市場的成長。當基因改變導致細胞不受控制地生長，破壞身體組織並形成腫塊（稱為腫瘤）時，癌症就開始了。腫瘤可以是癌性的，也可以是良性的。各種因素，包括基因突變、致癌物質、吸煙、肥胖、輻射和激素，都可能導致癌症的發展。隨著癌症患者數量的增加，對組織診斷等對於確定疾病進展至關重要的診斷技術的需求預計也會增加。例如，2024 年 2 月，總部位於瑞士的聯合國機構世界衛生組織 (WHO) 預測，到 2050 年新增癌症病例數將超過 3,500 萬，比 2022 年估計的 2,000 萬增加 77%。因此，癌症發生率的上升正在刺激組織診斷市場的擴張。

預計不斷成長的醫療支出將推動組織診斷市場的成長。醫療支出是指在特定期間內，國家或個人在醫療服務、治療和產品上的總支出。這些支出支持先進診斷技術、研究和醫療基礎設施（包括組織診斷）的開發、普及和利用。例如，美國非營利組織美國醫學會 ( 美國 Medical Association) 在 2024 年 7 月報告稱，從 2012 年到 2022 年，處方藥的複合年成長率將達到 4.7%，達到最高水平，而醫院護理和醫生服務的複合年成長率分別為 4.4% 和 4.2%。醫療支出的成長將推動診斷技術的進步，進一步刺激組織診斷市場的成長。

產品類型創新是組織診斷市場的一個發展趨勢，各公司推出的先進產品和解決方案能夠收集多種樣本類型、同時檢測多個樣本、實現實驗室程序自動化以及使診斷更容易獲得。競爭對手正專注於開發自動化組織診斷系統，以獲得競爭優勢並增加收益。例如，2022 年 6 月，瑞士醫療保健公司羅氏推出了用於癌症診斷的 BenchMark ULTRA PLUS 系統。該組織染色系統具有最佳化的工作流程、提高的檢測效率和永續的環境特性，使病理學家能夠為醫生和患者提供高品質、及時的結果。該系統的關鍵創新包括直覺的軟體、遠端監控功能、用於改善用戶體驗的整合觸控螢幕以及永續的廢棄物管理和包裝。

技術進步，尤其是人工智慧 (AI) 的整合，正在影響組織診斷市場。 AI 正被用於分析醫學影像和病理數據，從而提高疾病檢測和分類的準確性和效率。例如，Qritive 於 2023 年推出了 Qai Prostate，這是一款基於 AI 的前列腺癌檢測工具，為病理學家提供了先進的功能，能夠檢測和分類切片檢查組織樣本中惡性和良性腫瘤的位置。此次 AI 的融合是組織診斷市場提高癌症診斷和治療準確性的策略性舉措。

2022年2月的亮點是Labcorp以5.75億美元收購了Personal Genome Diagnostics (PGDx)。此次收購增強了Labcorp基於次世代定序的基因組分析能力，並增強了其現有的液態切片能力，體現了業界對癌症基因組學進步的決心。

參與組織診斷市場的主要企業包括 F. Hoffmann-La Roche Ltd.、Danaher Corporation、Thermo Fisher Scientific Inc.、Abbott Laboratories、Agilent Technologies Inc.、Merck KGaA、BioGenex Laboratories、Sakura Finetek Co.、Philips Healthcare NV、Bio-Rad Laboratories、Hoanax Corporation、Cell Signaling Technology Inc.、Enzo Life Sciences Inc.、Epitomics Inc.、Fluidigm Corporation、GE Healthcare Technologies Inc.、Genomic Health Inc.、Illumina Health Inc.、Agilent Technologies Inc.、Merck KGaA、BioGenex Laboratories、 Sakura Finetek Co.、Genomic Health系統Srl、Myriad Genetics Inc.、NanoString Technologies Inc.、PerkinElmer Inc.、QIAGEN NV、Siemens Healthineers AG、蔡司集團、CytomX Therapeutics Inc.

2024 年，北美是組織診斷市場最大的地區。全球組織診斷市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

組織診斷市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

組織診斷市場涵蓋營業單位從耗材和儀器中獲得的收益。市場價值包括服務供應商銷售或包含在服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球組織評估：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球組織診斷市場：成長率分析
• 全球組織診斷市場表現：規模與成長，2019-2024
• 全球組織診斷市場預測：規模與成長，2024-2029年，2034年
• 全球組織評估：總目標市場（TAM）

第6章 市場細分

• 全球組織診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 耗材
• 抗體
• 套件
• 試劑
• 探測
• 裝置
• 玻片染色系統
• 掃描器
• 組織處理系統
• 全球組織診斷市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 免疫組織化學（IHC）
• 原位雜合技術（ISH）
• 數位病理學和工作流程管理
• 特殊染色
• 全球組織診斷市場：依疾病、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 乳癌
• 胃癌
• 淋巴瘤
• 攝護腺癌
• 非小細胞肺癌（NSCLC）
• 全球組織診斷市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 研究辦公室
• 製藥公司
• 合約研究組織
• 全球組織診斷市場：按耗材細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 切片穿刺針
• 玻片和蓋玻片
• 組織包埋材料
• 全球組織診斷市場：按抗體類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 一抗
• 二抗
• 單株抗體
• 多株抗體
• 全球組織診斷市場：依試劑盒類型套件，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 診斷試劑套件
• 檢測試劑套件
• 染色試劑套件
• 全球組織診斷市場：按試劑類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 穩定劑
• 染色試劑
• 抗原活化溶液
• 全球組織診斷市場：按探針細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 螢光探針
• 分子探針
• 雜合反應探針
• 全球組織診斷市場：依設備類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 顯微鏡
• 組織微陣列儀
• 雷射捕獲晶粒儀
• 全球組織診斷市場：玻片染色系統細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 自動染色設備
• 手動染色系統
• 全球組織診斷市場：按掃描器類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 數位幻燈片掃描儀
• 全幻燈片成像系統
• 全球組織診斷市場：依組織處理系統細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 組織處理裝置
• 嵌入式中心
• 切片機

第7章 區域和國家分析

• 全球組織診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球組織診斷市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 組織診斷市場：競爭格局
• 組織診斷市場：公司簡介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Merck KGaA
• BioGenex Laboratories
• Sakura Finetek Co. Ltd.
• Philips Healthcare NV
• Bio-Rad Laboratories
• Ventana Medical Systems Inc.
• Hologic Inc.
• Becton Dickinson and Company
• Sysmex Corporation
• Cell Signaling Technology Inc.
• Enzo Life Sciences Inc.
• Epitomics Inc.
• Fluidigm Corporation
• GE Healthcare Technologies Inc.
• Genomic Health Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年組織診斷市場：提供新機會的國家
• 2029年組織診斷市場：細分市場帶來新機會
• 2029年組織診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of products in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue diagnostic market research report is one of a series of new reports from The Business Research Company that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue diagnostic market size has grown rapidly in recent years. It will grow from $5.77 billion in 2024 to $6.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, cancer prevalence, technological advancements, increased disease awareness, pathology workflow efficiency.

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.58 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to personalized medicine growth, rise of liquid biopsies, ai and machine learning adoption, telepathology expansion, minimally invasive techniques. Major trends in the forecast period include digital pathology, artificial intelligence (ai), telepathology services, multiplex staining and imaging, integration of genomic data.

The forecast of 13.5% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for immunohistochemistry antibodies and automated staining reagents, sourced from key regions such as Denmark and Sweden, could lead to delays in cancer detection and increased pathology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is expected to drive the growth of the tissue diagnostic market in the coming years. Cancer begins when genetic changes cause cells to grow uncontrollably, destroying body tissue and forming a mass known as a tumor, which can be either cancerous or benign. Various factors, including genetic mutations, carcinogens, smoking, obesity, radiation, and hormones, can lead to the development of cancer. As cancer cases rise, the demand for diagnostic procedures like tissue diagnostics will grow, as these are essential in determining the disease's progression. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the rising cancer incidence is fueling the expansion of the tissue diagnostic market.

The increasing healthcare expenditure is expected to drive the growth of the tissue diagnostic market. Healthcare expenditure refers to the total amount of money spent on healthcare services, treatments, and products over a certain period, either at the national or individual level. This spending supports the development, accessibility, and utilization of advanced diagnostic technologies, research, and medical infrastructure, including tissue diagnostics. For example, in July 2024, the American Medical Association, a US-based nonprofit organization, reported that from 2012 to 2022, the average annual growth rate for prescription drugs was the highest at 4.7%, compared to 4.4% for hospital care and 4.2% for physician services. This increase in healthcare spending helps foster advancements in diagnostic technologies, driving the growth of the tissue diagnostic market.

Product innovation is a growing trend in the tissue diagnostic market, with companies introducing advanced products and solutions that can collect multiple sample types, test multiple samples simultaneously, automate lab operations, and make diagnostics more accessible. Leading players are focusing on developing automated tissue diagnostic systems to gain a competitive advantage and boost revenue. For instance, in June 2022, Roche, a Switzerland-based healthcare company, launched the BenchMark ULTRA PLUS system for cancer diagnostics. This tissue staining system features optimized workflow, enhanced testing efficiency, and sustainable environmental features, allowing pathologists to deliver high-quality, timely results to doctors and patients. Key innovations in the system include intuitive software, remote monitoring capabilities, an integrated touchscreen for a better user experience, and environmentally sustainable waste management and packaging.

The technological advancements, particularly the integration of artificial intelligence (AI), are influencing the tissue diagnostic market. AI is employed to analyze medical images and pathological data, enhancing the accuracy and efficiency of disease detection and classification. For instance, in 2023, Qritive introduced the Qai Prostate, an AI-powered prostate cancer detection tool, providing pathologists with advanced capabilities for detecting and classifying malignant and benign tumor locations in biopsy tissue samples. This integration of AI represents a strategic move to improve precision in cancer diagnosis and treatment within the tissue diagnostic market.

In February 2022, Labcorp's acquisition of Personal Genome Diagnostics (PGDx) for $575 million stands out. This move strengthens Labcorp's next-generation sequencing-based genomic profiling capabilities and enhances existing liquid biopsy capabilities, reflecting the industry's commitment to advancing cancer genomics.

Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the global tissue diagnostic industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The tissue diagnostic market includes revenues earned by entities by consumables and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
• 2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
• 3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
• 4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations
• Subsegments:
• 1) By Consumables: Biopsy Needles; Slides And Cover Slips; Tissue Embedding Materials
• 2) By Antibodies: Primary Antibodies; Secondary Antibodies; Monoclonal Antibodies; Polyclonal Antibodies
• 3) By Kits: Diagnostic Kits; Assay Kits; Staining Kits
• 4) By Reagents: Fixatives; Staining Reagents; Antigen Retrieval Solutions
• 5) By Probes: Fluorescent Probes; Molecular Probes; Hybridization Probes
• 6) By Instruments: Microscopes; Tissue Microarray Instruments; Laser Capture Microdissection Instruments
• 7) By Slide Staining System: Automated Stainers; Manual Staining Systems
• 8) By Scanner: Digital Slide Scanners; Whole Slide Imaging Systems
• 9) By Tissue Processing System: Tissue Processors; Embedding Centers; Microtomes
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Agilent Technologies Inc.; Merck KGaA; BioGenex Laboratories; Sakura Finetek Co. Ltd.; Philips Healthcare NV; Bio-Rad Laboratories; Ventana Medical Systems Inc.; Hologic Inc.; Becton Dickinson and Company; Sysmex Corporation; Cell Signaling Technology Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; Fluidigm Corporation; GE Healthcare Technologies Inc.; Genomic Health Inc.; Illumina Inc.; Leica Microsystems GmbH; Menarini Diagnostics S.r.l; Myriad Genetics Inc.; NanoString Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.; Siemens Healthineers AG; Zeiss Group AG; CytomX Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Diagnostic Market Characteristics

3. Tissue Diagnostic Market Trends And Strategies

4. Tissue Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Diagnostic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Diagnostic Market Growth Rate Analysis
• 5.4. Global Tissue Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Diagnostic Total Addressable Market (TAM)

6. Tissue Diagnostic Market Segmentation

• 6.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Antibodies
• Kits
• Reagents
• Probes
• Instruments
• Slide Staining System
• Scanner
• Tissue Processing system
• 6.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Digital Pathology And Workflow Management
• Special Staining
• 6.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• 6.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations
• 6.5. Global Tissue Diagnostic Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Needles
• Slides And Cover Slips
• Tissue Embedding Materials
• 6.6. Global Tissue Diagnostic Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Antibodies
• Secondary Antibodies
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.7. Global Tissue Diagnostic Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Kits
• Assay Kits
• Staining Kits
• 6.8. Global Tissue Diagnostic Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fixatives
• Staining Reagents
• Antigen Retrieval Solutions
• 6.9. Global Tissue Diagnostic Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Probes
• Molecular Probes
• Hybridization Probes
• 6.10. Global Tissue Diagnostic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microscopes
• Tissue Microarray Instruments
• Laser Capture Microdissection Instruments
• 6.11. Global Tissue Diagnostic Market, Sub-Segmentation Of Slide Staining System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Stainers
• Manual Staining Systems
• 6.12. Global Tissue Diagnostic Market, Sub-Segmentation Of Scanner, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Slide Scanners
• Whole Slide Imaging Systems
• 6.13. Global Tissue Diagnostic Market, Sub-Segmentation Of Tissue Processing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Processors
• Embedding Centers
• Microtomes

7. Tissue Diagnostic Market Regional And Country Analysis

• 7.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Diagnostic Market

• 8.1. Asia-Pacific Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Diagnostic Market

• 9.1. China Tissue Diagnostic Market Overview
• 9.2. China Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Diagnostic Market

• 10.1. India Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Diagnostic Market

• 11.1. Japan Tissue Diagnostic Market Overview
• 11.2. Japan Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Diagnostic Market

• 12.1. Australia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Diagnostic Market

• 13.1. Indonesia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Diagnostic Market

• 14.1. South Korea Tissue Diagnostic Market Overview
• 14.2. South Korea Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Diagnostic Market

• 15.1. Western Europe Tissue Diagnostic Market Overview
• 15.2. Western Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Diagnostic Market

• 16.1. UK Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Diagnostic Market

• 17.1. Germany Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Diagnostic Market

• 18.1. France Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Diagnostic Market

• 19.1. Italy Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Diagnostic Market

• 20.1. Spain Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Diagnostic Market

• 21.1. Eastern Europe Tissue Diagnostic Market Overview
• 21.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Diagnostic Market

• 22.1. Russia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Diagnostic Market

• 23.1. North America Tissue Diagnostic Market Overview
• 23.2. North America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Diagnostic Market

• 24.1. USA Tissue Diagnostic Market Overview
• 24.2. USA Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Diagnostic Market

• 25.1. Canada Tissue Diagnostic Market Overview
• 25.2. Canada Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Diagnostic Market

• 26.1. South America Tissue Diagnostic Market Overview
• 26.2. South America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Diagnostic Market

• 27.1. Brazil Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Diagnostic Market

• 28.1. Middle East Tissue Diagnostic Market Overview
• 28.2. Middle East Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Diagnostic Market

• 29.1. Africa Tissue Diagnostic Market Overview
• 29.2. Africa Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Diagnostic Market Competitive Landscape And Company Profiles

• 30.1. Tissue Diagnostic Market Competitive Landscape
• 30.2. Tissue Diagnostic Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Diagnostic Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. BioGenex Laboratories
• 31.3. Sakura Finetek Co. Ltd.
• 31.4. Philips Healthcare NV
• 31.5. Bio-Rad Laboratories
• 31.6. Ventana Medical Systems Inc.
• 31.7. Hologic Inc.
• 31.8. Becton Dickinson and Company
• 31.9. Sysmex Corporation
• 31.10. Cell Signaling Technology Inc.
• 31.11. Enzo Life Sciences Inc.
• 31.12. Epitomics Inc.
• 31.13. Fluidigm Corporation
• 31.14. GE Healthcare Technologies Inc.
• 31.15. Genomic Health Inc.

32. Global Tissue Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Diagnostic Market

34. Recent Developments In The Tissue Diagnostic Market

35. Tissue Diagnostic Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Diagnostic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Diagnostic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Diagnostic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer